Skip to content

Asset turnover at other companies

AbbVie logo
AbbVieABBV
0.5×+0.1×
Bausch + Lomb logo
Bausch + LombBLCO
0.4×0.0×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
0.1×0.0×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
0.4×0.0×
Warby Parker logo
Warby ParkerWRBY
1.3×0.0×
Glaukos logo
GlaukosGKOS
0.6×+0.2×

Other financials

Income statement

See full
Revenue$162.1M+107%
Gross profit$152.7M+109%
Operating income-$6.1M+76.7%
Net income-$7.0M+72.3%
EPS (diluted)-$0.16+75.0%

Balance sheet

See full
Cash & equivalents$104.2M-41.6%
Total debt$88.7M+22.5%
Total equity$349.0M+1.9%
Total assets$581.1M+16.1%

Cash flow

See full
Operating cash flow-$24.7M-19.4%
CapEx$5.8M+886%
Free cash flow-$30.5M-43.4%

Valuation

See full
Market cap$2.85B+41.1%
Enterprise value$2.83B+47.8%
P/S5.3×-3.3×

Profitability

See full
Gross margin42.7%
Operating margin-9.5%-4.2pp
Net margin-9%-4.0pp
FCF margin-28%-12.6pp

Returns & leverage

See full
Return on equity-14%-5.2pp
Debt / equity0.3×0.0×
Current ratio3.7×-1.8×

Where this comes from

Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tarsus Pharmaceuticals, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tarsus Pharmaceuticals, Inc.'s asset turnover?
Tarsus Pharmaceuticals, Inc. (TARS) reported asset turnover of 1× in Q1 2026.
How has Tarsus Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
Tarsus Pharmaceuticals, Inc.'s asset turnover increased by 79.9% year-over-year, from 0.5× to 1×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.